chr19-33302057-T-G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_004364.5(CEBPA):​c.358A>C​(p.Met120Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000094 in 1,064,114 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M120V) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 9.4e-7 ( 0 hom. )

Consequence

CEBPA
NM_004364.5 missense

Scores

2
17

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.12

Publications

0 publications found
Variant links:
Genes affected
CEBPA (HGNC:1833): (CCAAT enhancer binding protein alpha) This intronless gene encodes a transcription factor that contains a basic leucine zipper (bZIP) domain and recognizes the CCAAT motif in the promoters of target genes. The encoded protein functions in homodimers and also heterodimers with CCAAT/enhancer-binding proteins beta and gamma. Activity of this protein can modulate the expression of genes involved in cell cycle regulation as well as in body weight homeostasis. Mutation of this gene is associated with acute myeloid leukemia. The use of alternative in-frame non-AUG (GUG) and AUG start codons results in protein isoforms with different lengths. Differential translation initiation is mediated by an out-of-frame, upstream open reading frame which is located between the GUG and the first AUG start codons. [provided by RefSeq, Dec 2013]
CEBPA-DT (HGNC:25710): (CEBPA divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.11970997).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CEBPANM_004364.5 linkc.358A>C p.Met120Leu missense_variant Exon 1 of 1 ENST00000498907.3 NP_004355.2 P49715-1
CEBPANM_001287424.2 linkc.463A>C p.Met155Leu missense_variant Exon 1 of 1 NP_001274353.1 P49715-4
CEBPANM_001287435.2 linkc.316A>C p.Met106Leu missense_variant Exon 1 of 1 NP_001274364.1 P49715-2
CEBPANM_001285829.2 linkc.1A>C p.Met1? initiator_codon_variant Exon 1 of 1 NP_001272758.1 P49715-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CEBPAENST00000498907.3 linkc.358A>C p.Met120Leu missense_variant Exon 1 of 1 6 NM_004364.5 ENSP00000427514.1 P49715-1
CEBPA-DTENST00000718467.1 linkn.46+258T>G intron_variant Intron 1 of 1
ENSG00000267727ENST00000587312.1 linkn.*117T>G downstream_gene_variant 3

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
9.40e-7
AC:
1
AN:
1064114
Hom.:
0
Cov.:
33
AF XY:
0.00
AC XY:
0
AN XY:
504846
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
21412
American (AMR)
AF:
0.00
AC:
0
AN:
7122
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
12536
East Asian (EAS)
AF:
0.00
AC:
0
AN:
23114
South Asian (SAS)
AF:
0.00
AC:
0
AN:
20958
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
30254
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2728
European-Non Finnish (NFE)
AF:
0.00000111
AC:
1
AN:
904866
Other (OTH)
AF:
0.00
AC:
0
AN:
41124
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.375
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
19
DANN
Benign
0.82
DEOGEN2
Benign
0.17
T
Eigen
Benign
-0.61
Eigen_PC
Benign
-0.43
FATHMM_MKL
Benign
0.75
D
LIST_S2
Benign
0.42
T
M_CAP
Pathogenic
0.53
D
MetaRNN
Benign
0.12
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.34
N
PhyloP100
1.1
PrimateAI
Pathogenic
0.95
D
PROVEAN
Benign
-0.14
N
REVEL
Benign
0.050
Sift
Benign
0.61
T
Sift4G
Benign
0.69
T
Polyphen
0.0010
B
Vest4
0.20
MutPred
0.27
Gain of sheet (P = 0.1208);
MVP
0.085
ClinPred
0.052
T
GERP RS
3.6
PromoterAI
-0.063
Neutral
Varity_R
0.15
gMVP
0.20
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1555742209; hg19: chr19-33792963; API